← Evidence map

ArticleThe Lancet. Rheumatology2022

Who, what, and when-effective therapy for severe COVID-19.

Daniel A Kelmenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34812425